Group One Trading
LKFT

Group One Trading’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Group One Trading’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.55M Hold
51,800
– – ﹤0.01% 2466
2026
Q1 		$1.55M Buy
+51,800
New +$1.72M ﹤0.01% 2297
2025
Q2 		– Sell
-500
Closed -$12.6K – 8170
2025
Q1 		$12.6K Sell
500
-100
-17% -$2.53K ﹤0.01% 6111
2024
Q4 		$16.5K Sell
600
-2,000
-77% -$55.8K ﹤0.01% 5825
2024
Q3 		$74.9K Buy
2,600
+500
+24% +$13.6K ﹤0.01% 4388
2024
Q2 		$52K Buy
+2,100
New +$59.6K ﹤0.01% 4505
2024
Q1 		– Sell
-44,800
Closed -$1.82M – 7372
2023
Q4 		$1.82M Buy
44,800
+44,000
+5,500% +$1.62M ﹤0.01% 1953
2023
Q3 		$27.6K Sell
800
-72,800
-99% -$2.83M ﹤0.01% 5621
2023
Q2 		$2.99M Sell
73,600
-2,500
-3% -$102K 0.01% 1359
2023
Q1 		$2.94M Sell
76,100
-500
-0.7% -$20.6K 0.01% 1222
2022
Q4 		$3.4M Buy
76,600
+60,700
+382% +$2.55M 0.01% 1408
2022
Q3 		$678K Sell
15,900
-32,600
-67% -$1.67M ﹤0.01% 2932
2022
Q2 		$2.71M Buy
48,500
+30,200
+165% +$1.79M ﹤0.01% 1778
2022
Q1 		$1.14M Buy
18,300
+11,300
+161% +$692K ﹤0.01% 2960
2021
Q4 		$386K Sell
7,000
-31,100
-82% -$1.62M ﹤0.01% 4408
2021
Q3 		$2M Buy
38,100
+10,000
+36% +$594K ﹤0.01% 2651
2021
Q2 		$1.94M Sell
28,100
-77,300
-73% -$5.9M ﹤0.01% 2688
2021
Q1 		$8.13M Buy
105,400
+101,100
+2,351% +$9.31M 0.01% 1103
2020
Q4 		$426K Sell
4,300
-19,800
-82% -$2.42M ﹤0.01% 3408
2020
Q3 		$3.42M Sell
24,100
-12,700
-35% -$2.12M 0.01% 1177
2020
Q2 		$7.26M Sell
36,800
-13,500
-27% -$2.8M 0.03% 588
2020
Q1 		$9.86M Buy
50,300
+7,200
+17% +$1.55M 0.08% 259
2019
Q4 		$8.91M Sell
43,100
-36,100
-46% -$6.67M 0.06% 398
2019
Q3 		$12.1M Buy
79,200
+1,700
+2% +$279K 0.1% 218
2019
Q2 		$9.99M Buy
77,500
+28,000
+57% +$3.32M 0.09% 231
2019
Q1 		$5.83M Buy
49,500
+39,500
+395% +$3.98M 0.07% 362
2018
Q4 		$917K Hold
10,000
– – 0.01% 1567
2018
Q3 		$1.12M Buy
+10,000
New +$1.06M 0.01% 1618

Other funds holding LKFT

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
DCM
DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Group One Trading's LKFT Position: Q2 2026 in Review

Group One Trading increased its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 246% in Q2 2026, buying an estimated $355K and bringing the position to 17,577 shares worth $527K. The position accounts for ﹤0.01% of the portfolio, ranked #3449.

Group One Trading first reported a position in LKFT in Q3 2018 and has held it in 25 quarters since. The position peaked at $4.83M in Q1 2020. 76 funds tracked by Wall St. Rank hold LKFT as of Q2 2026.

  • Group One Trading held 17,577 shares of Lakefront Biotherapeutics American Depositary Shares worth $527K as of Q2 2026.
  • Group One Trading bought 12,495 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2026, an estimated $355K.
  • Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #3449 holding.
  • Group One Trading first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2018 and has held it in 25 quarters since.
  • Group One Trading's Lakefront Biotherapeutics American Depositary Shares position peaked at $4.83M in Q1 2020.
  • 76 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.